Alzheimer disease effects of different stages on intestinal flora: A protocol for systematic review and meta-analysis. Issue 52 (30th December 2021)

• Record Type: Journal Article
• Authors: Cheng, Xunshu; Wang, Haorui; Zheng, Zhihuang; Feng, Ke; Tang, Saixue; Liu, Yuanyuan; Chen, Ke; Bi, Chenhao; Gao, Mingzhou; Ji, Lijin
• Is Part Of: Medicine. Volume 100:Issue 52(2021)
• Publication Date: 2021-12-30
• Subjects: Alzheimer disease -- dementia -- gastrointestinal microbiome -- META -- probiotics; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000028462
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Background: Alzheimer disease (AD) is a common degenerative disease of the central nervous system that can be divided into 3 stages, according to the degree of cognitive impairment. The clinical manifestations are cognitive dysfunction and memory loss, impacting the daily activities of the affected individuals. In recent years, studies have demonstrated a relationship between intestinal flora and AD. However, no meta-analysis has documented the correlation between AD and intestinal flora, to the best of our knowledge. Herein, we sought to assess the correlation between different stages of AD and intestinal flora. A systematic and comprehensive understanding of this relationship is of great significance for developing prevention and treatment strategies against AD. Methods: A comprehensive search of the medical literature in Chinese and English language was performed in databases, such as PubMed, EBSCO, CNKI, web of science, WanFang, Cochrane Library, and CBM databases. Pre-defined search strategies were used to retrieve clinical studies of Alzheimer disease and gut microbiota. The included studies were independently analyzed by the 2 researchers who extracted the data. The quality of the data was evaluated according to the "Cochrane system evaluator manual." Finally, Endnote and RevMan software were used for systematic regression and meta-analysis of evidence. Results: We documented the intestinal flora changes in the 3 stages of Alzheimer disease, according to currently available clinical evidence, and revealed the correlation between the abundance and diversity of flora and treatment efficacy. These findings are essential for developing new strategies for the prevention and treatment of Alzheimer disease. INPLASY registration number: INPLASY2021100093 Ethics and dissemination: Since all data utilized in this systematic review and meta-analysis are published, ethical approval was not needed.